That report was issued on 6th October....we should see that which is alluded to in the report all come true next week with the issue of the first molyb assays.
CYL has a tiny mkt cap in both heads and options...hardly any sell depth...
On publication of the assays next week the share price should also discount the release of the final assays due in late January - this should create support levels at much higher sp than where it is now...
all imo of course
and yes I do hold CYLO
EB
CYL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held